Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0837 SEK | 0.00% | -16.30% | +39.50% |
02-20 | S2Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
02-20 | S2Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 10.96M 0 0 | Sales 2022 | 6.16M 0 0 | Capitalization | 22.09M 0 0 |
---|---|---|---|---|---|
Net income 2021 | -20M - - | Net income 2022 | -29M - - | EV / Sales 2021 | 6.36 x |
Net cash position 2021 | 9.27M 0 0 | Net cash position 2022 | 3.72M 0 0 | EV / Sales 2022 | 2.98 x |
P/E ratio 2021 |
-3.88
x | P/E ratio 2022 |
-0.55
x | Employees | 20 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 59.66% |
1 week | -16.30% | ||
Current month | +7.31% | ||
1 month | +16.25% | ||
3 months | -1.30% | ||
6 months | +298.57% | ||
Current year | +39.50% |
Managers | Title | Age | Since |
---|---|---|---|
Petter Sivlér
CEO | Chief Executive Officer | 39 | 13-06-12 |
Mårten Skog
FOU | Founder | 42 | 13-06-12 |
Ingvild Pizarro
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Miles Wright
BRD | Director/Board Member | 63 | 21-12-31 |
Mårten Skog
FOU | Founder | 42 | 13-06-12 |
Fredrik Skog
CHM | Chairman | 41 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.0837 | 0.00% | 632,276 |
24-04-30 | 0.0837 | -3.13% | 1,858,029 |
24-04-29 | 0.0864 | -10.74% | 2,592,573 |
24-04-26 | 0.0968 | +1.89% | 2,192,150 |
24-04-25 | 0.095 | +0.32% | 2,206,243 |
Delayed Quote Nasdaq Stockholm, May 02, 2024 at 11:24 am
More quotes1st Jan change | Capi. | |
---|---|---|
+39.50% | 2.1M | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- S2M Stock